<?xml version="1.0" encoding="UTF-8"?>
<ref id="B46">
 <label>46</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Zhang</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>Z</given-names>
   </name>
   <name>
    <surname>Yang</surname>
    <given-names>Z</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>Y</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Phase I Escalating-Dose Trial of CAR-T Therapy Targeting CEA+ Metastatic Colorectal Cancers</article-title>. 
  <source>Mol Ther</source> (
  <year>2017</year>) 
  <volume>25</volume>(
  <issue>5</issue>):
  <page-range>1248–58</page-range>.  
  <pub-id pub-id-type="doi">10.1016/j.ymthe.2017.03.010</pub-id>
 </mixed-citation>
</ref>
